PRIMARY STUDY
Prospective affirmative therapeutics of cannabidiol oil mitigates doxorubicin-induced abnormalities in kidney function, inflammation, and renal tissue changes
Key Findings: Cannabidiol (CBD) led to a noticeable improvement in oxidative stress parameters and renal and liver function in this rat model of doxorubicin-induced nephropathy
Type of Study: Animal Study
Study Sample Size: 250
Study Result: Positive
Research Location(s): Egypt
Year of Pub: 2024
Cannabinoids Studied: Cannabidiol (CBD), Pharma CBD
Phytocannabinoid Source: Not Applicable
Chemotype: Chemotype III
Ligands Studied: Pro-inflammatory cytokines
Citation: Soliman NA, Dahmy SIE, Shalaby AA, Mohammed KA. Prospective affirmative therapeutics of cannabidiol oil mitigates doxorubicin-induced abnormalities in kidney function, inflammation, and renal tissue changes. Naunyn Schmiedebergs Arch Pharmacol. 2024 Jun;397(6):3897-3906. doi: 10.1007/s00210-023-02836-4. Epub 2023 Nov 16. PMID: 37971510; PMCID: PMC11111484.
